The first half of 2026 confirmed a structural shift, not a cyclical one. Consolidation, localisation, regulatory reform and AI adoption are accelerating together, and the organisations navigating all four have one thing in common: leadership teams built for complexity, not just scale.

This report gives you a clear, search-side view of what that means for who you hire, retain and develop in the second half of the year.

• Generics & biosimilars M&A — the H1 deal wave and the surge in demand for “integration-ready” GMs and SVPs of Business Development
• The localisation surge — reshoring, the EU Biotech Act, US tariff catalysts and the rise of the “Global Operational Architect”
• Leadership in execution — how Lupin, Polpharma, Sandoz, Remedica and Viatris turned strategy into defensible market positions
• AI & the digital generics era — why the AI skills gap is a hiring crisis in disguise, and the “bilingual” executives now in short supply
• CDMO market snapshot — how CDMO selection became a board-level, leadership-led decision
• The relocation reality — what 240+ senior professionals told us about moving for the right role
• The Parsity Group H2 2026 Leadership Agenda — three hiring priorities for the next six months

Download your free copy today to understand the strategic recalibration underway and prepare your organisation for H2.